391 related articles for article (PubMed ID: 24647709)
41. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats.
Danielson LA; Conrad KP
J Appl Physiol (1985); 2003 Oct; 95(4):1509-14. PubMed ID: 12819218
[TBL] [Abstract][Full Text] [Related]
42. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats.
Conrad KP; Debrah DO; Novak J; Danielson LA; Shroff SG
Endocrinology; 2004 Jul; 145(7):3289-96. PubMed ID: 15198972
[TBL] [Abstract][Full Text] [Related]
43. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
[TBL] [Abstract][Full Text] [Related]
44. Renal hemodynamic effects of relaxin in humans.
Smith M; Davison J; Conrad K; Danielson L
Ann N Y Acad Sci; 2005 May; 1041():163-72. PubMed ID: 15956702
[TBL] [Abstract][Full Text] [Related]
45. Relaxin Deficiency Leads to Uterine Artery Dysfunction During Pregnancy in Mice.
Marshall SA; Senadheera SN; Jelinic M; O'Sullivan K; Parry LJ; Tare M
Front Physiol; 2018; 9():255. PubMed ID: 29623045
[TBL] [Abstract][Full Text] [Related]
46. Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF.
Denney JM; Bird C; Gendron-Fitzpatrick A; Sampene E; Bird IM; Shah DM
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F445-F455. PubMed ID: 27927648
[TBL] [Abstract][Full Text] [Related]
47. The vascular actions of relaxin.
Jeyabalan A; Shroff SG; Novak J; Conrad KP
Adv Exp Med Biol; 2007; 612():65-87. PubMed ID: 18161482
[TBL] [Abstract][Full Text] [Related]
48. Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.
McGuane JT; Debrah JE; Sautina L; Jarajapu YP; Novak J; Rubin JP; Grant MB; Segal M; Conrad KP
Endocrinology; 2011 Jul; 152(7):2786-96. PubMed ID: 21558316
[TBL] [Abstract][Full Text] [Related]
49. Renal functional, transcriptome, and methylome adaptations in pregnant Sprague Dawley and Brown Norway rats.
Chen Z; Wang C; Blood A; Bragg S; Mata-Greenwood E
PLoS One; 2022; 17(6):e0269792. PubMed ID: 35709218
[TBL] [Abstract][Full Text] [Related]
50. Age-related changes in renal hemodynamics in female rats: role of multiple pregnancy and NO.
Reckelhoff JF
Am J Physiol; 1997 Jun; 272(6 Pt 2):R1985-9. PubMed ID: 9227618
[TBL] [Abstract][Full Text] [Related]
51. Cyclooxygenase products do not contribute to the gestational renal vasodilation in the nitric oxide synthase inhibited pregnant rat.
Baylis C
Hypertens Pregnancy; 2002; 21(2):109-14. PubMed ID: 12175438
[TBL] [Abstract][Full Text] [Related]
52. Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.
Santiago-Font JA; Amaral LM; Faulkner J; Ibrahim T; Vaka VR; Cunningham MW; LaMarca B
Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1158-R1163. PubMed ID: 27629886
[TBL] [Abstract][Full Text] [Related]
53. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
Amuchastegui CS; Remuzzi G; Perico N
Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of renal vasodilation and hyperfiltration during pregnancy: current perspectives and potential implications for preeclampsia.
Conrad KP; Novak J; Danielson LA; Kerchner LJ; Jeyabalan A
Endothelium; 2005; 12(1-2):57-62. PubMed ID: 16036316
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats.
Alexander BT; Miller MT; Kassab S; Novak J; Reckelhoff JF; Kruckeberg WC; Granger JP
Hypertension; 1999 Jan; 33(1 Pt 2):435-9. PubMed ID: 9931143
[TBL] [Abstract][Full Text] [Related]
56. From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system.
Jelinic M; Marshall SA; Leo CH; Parry LJ; Tare M
Microcirculation; 2019 Feb; 26(2):e12464. PubMed ID: 29876993
[TBL] [Abstract][Full Text] [Related]
57. Effects of continuous infusion of endothelin-1 in pregnant sheep.
Greenberg SG; Baker RS; Yang D; Clark KE
Hypertension; 1997 Dec; 30(6):1585-90. PubMed ID: 9403587
[TBL] [Abstract][Full Text] [Related]
58. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
59. Luteal and hypophyseal expression of the canine relaxin (RLN) system during pregnancy: Implications for luteotropic function.
Nowak M; Boos A; Kowalewski MP
PLoS One; 2018; 13(1):e0191374. PubMed ID: 29364921
[TBL] [Abstract][Full Text] [Related]
60. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats.
Novak J; Ramirez RJ; Gandley RE; Sherwood OD; Conrad KP
Am J Physiol Regul Integr Comp Physiol; 2002 Aug; 283(2):R349-55. PubMed ID: 12121847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
